Jeremy Bender - 16 Oct 2023 Form 4 Insider Report for Fusion Pharmaceuticals Inc. (FUSN)

Role
Director
Signature
/s/Maria Stahl as Attorney-in-Fact for Jeremy Bender
Issuer symbol
FUSN
Transactions as of
16 Oct 2023
Transactions value $
$0
Form type
4
Filing time
16 Oct 2023, 16:58:19 UTC
Previous filing
17 Aug 2023
Next filing
17 Nov 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FUSN Stock Option (Right to Buy) Award $0 +34,000 $0.000000 34,000 16 Oct 2023 Common Stock 34,000 $4.16 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest and become exercisable in 36 substantially equal monthly installments starting on November 16, 2023.